| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.45 | 3e-05 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.48 | 0.004 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.52 | 0.006 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.41 | 0.009 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -1.9 | 0.01 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |